We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+16.45%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$157M
AUM Growth
+$19.3M
Cap. Flow
+$6.96M
Cap. Flow %
4.45%
Top 10 Hldgs %
59.23%
Holding
147
New
34
Increased
35
Reduced
16
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 36.93%
2 Healthcare 27.25%
3 Financials 7.02%
4 Consumer Discretionary 4.71%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSR
101
DELISTED
Whitestone REIT
WSR
$82K 0.05%
10,300
LITS
102
Lite Strategy Inc
LITS
$30.7M
$80K 0.05%
+1,510
New +$87.1K
RIGL icon
103
Rigel Pharmaceuticals
RIGL
$785M
$79K 0.05%
2,254
-926
-29% -$26.8K
VBIV
104
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$79K 0.05%
953
RLGT icon
105
Radiant Logistics
RLGT
$391M
$75K 0.05%
12,900
AGEN
106
Agenus
AGEN
$307M
$73K 0.05%
1,167
HROW icon
107
Harrow
HROW
$1.47B
$71K 0.05%
10,300
TEO icon
108
Telecom Argentina
TEO
$5.81B
$71K 0.05%
10,800
SBBP
109
DELISTED
Strongbridge Biopharma plc.
SBBP
$69K 0.04%
28,432
+5,332
+23% +$12.8K
LAB icon
110
Standard BioTools
LAB
$309M
$66K 0.04%
11,000
VXRT
111
DELISTED
Vaxart
VXRT
$66K 0.04%
11,600
RMNI icon
112
Rimini Street
RMNI
$449M
$60K 0.04%
+13,499
New +$53.3K
VKTX icon
113
Viking Therapeutics
VKTX
$3.94B
$57K 0.04%
10,100
EPM icon
114
Evolution Petroleum
EPM
$135M
$56K 0.04%
19,800
OSG
115
DELISTED
Overseas Shipholding Group Inc.
OSG
$56K 0.04%
26,400
ACTG icon
116
Acacia Research
ACTG
$451M
$55K 0.04%
+13,977
New +$50.1K
CDTX
117
DELISTED
Cidara Therapeutics
CDTX
$42K 0.03%
1,060
BDTX icon
118
Black Diamond Therapeutics
BDTX
$120M
-16,391
Closed -$496K
BZH icon
119
Beazer Homes USA
BZH
$874M
-10,300
Closed -$136K
CRNX icon
120
Crinetics Pharmaceuticals
CRNX
$8.95B
-30,845
Closed -$483K
CTMX icon
121
CytomX Therapeutics
CTMX
$752M
-13,000
Closed -$86K
DHX icon
122
DHI Group
DHX
$166M
-15,100
Closed -$34K
DNLI icon
123
Denali Therapeutics
DNLI
$3.95B
-15,734
Closed -$564K
DVAX
124
DELISTED
Dynavax Technologies
DVAX
-14,700
Closed -$64K
FATE icon
125
Fate Therapeutics
FATE
$319M
-13,807
Closed -$552K

Similar funds

HighVista Strategies's Q4 2020 Portfolio in Review

As of Q4 2020, HighVista Strategies held 147 positions worth $157M, up 14% from $137M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

HighVista Strategies deployed $6.96M of net new capital in Q4 2020, opening 34 new positions and adding to 35 existing holdings. Its largest new stake was DouYu International Holdings: 24,960 shares worth $2.76M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $1.25M trimmed.

  • HighVista Strategies's largest Q4 2020 buy was DouYu International Holdings: 24,960 shares worth $2.76M.
  • HighVista Strategies added most to Adaptimmune Therapeutics in Q4 2020, an estimated $564K increase.
  • HighVista Strategies's biggest Q4 2020 reduction was Alibaba, cutting an estimated $1.25M.
  • HighVista Strategies fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $7.15M.
  • HighVista Strategies's ten largest holdings make up 59% of its $157M portfolio in Q4 2020.
  • HighVista Strategies opened 34 new positions and closed 30 in Q4 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $157M.

Based on HighVista Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.